Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
RESEARCH TOOLSreports
Sarepta Therapeutics (SRPT) Stock Price & Analysis
2,506 Followers
SRPT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$100.01 - $159.89
Previous Close$121.22
Volume916.82K
Average Volume (3M)898.04K
Market Cap
$11.31B
Enterprise Value$10.81B
Total Cash (Recent Filing)$1.86B
Total Debt (Recent Filing)$1.36B
Price to Earnings (P/E)-11.8
Beta0.95
Next Earnings
Nov 01, 2023EPS Estimate
-$1.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.31
Shares Outstanding93,278,902
10 Day Avg. Volume867,018
30 Day Avg. Volume898,041
Standard Deviation0.16
R-Squared0.11
Alpha0.00224
Financial Highlights & Ratios
Price to Book (P/B)15.25
Price to Sales (P/S)43.28
Price to Cash Flow (P/CF)-23.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.02
Enterprise Value/Gross Profit15.36
Enterprise Value/Ebitda-14.66
Forecast
1Y Price Target
$184.00Price Target Upside55.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Sarepta Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRPT FAQ
What was Sarepta Therapeutics’s price range in the past 12 months?
Sarepta Therapeutics lowest stock price was $100.01 and its highest was $159.89 in the past 12 months.
What is Sarepta Therapeutics’s market cap?
Currently, no data Available
When is Sarepta Therapeutics’s upcoming earnings report date?
Sarepta Therapeutics’s upcoming earnings report date is Nov 01, 2023 which is in 29 days.
How were Sarepta Therapeutics’s earnings last quarter?
Sarepta Therapeutics released its earnings results on Aug 02, 2023. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$1.777 by $1.507.
Is Sarepta Therapeutics overvalued?
According to Wall Street analysts Sarepta Therapeutics’s price is currently Undervalued.
Does Sarepta Therapeutics pay dividends?
Sarepta Therapeutics does not currently pay dividends.
What is Sarepta Therapeutics’s EPS estimate?
Sarepta Therapeutics’s EPS estimate is -$1.26.
How many shares outstanding does Sarepta Therapeutics have?
Sarepta Therapeutics has 93,278,900 shares outstanding.
What happened to Sarepta Therapeutics’s price movement after its last earnings report?
Sarepta Therapeutics reported an EPS of -$0.27 in its last earnings report, beating expectations of -$1.777. Following the earnings report the stock price went up 2.053%.
Which hedge fund is a major shareholder of Sarepta Therapeutics?
Among the largest hedge funds holding Sarepta Therapeutics’s share is Farallon Capital Management, L.L.C.. It holds Sarepta Therapeutics’s shares valued at 138M.
---
Sarepta Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$184.00 (55.16% Upside)
$184.00 (55.16% Upside)
Blogger Sentiment
Bullish
SRPT Sentiment 80%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 1.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $5.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
10.57%
12-Months-Change
Fundamentals
Return on Equity
-123.67%
Trailing 12-Months
Asset Growth
4.31%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sarepta Therapeutics
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding SRPT
Vanguard Total Stock Market ETF
$335.24M
Vanguard Health Care ETF
$33.29M
Vanguard Russell 1000 Growth ETF
$8.44M
Vanguard Russell 1000 ETF
$1.49M
Vanguard Russell 3000 ETF
$712.87K
Up to five ETFs with an Outperform Smart Score that hold SRPT. The ETFs are listed according to market value of SRPT within the ETF
BioMarin Pharmaceutical
―
Ionis Pharmaceuticals
―
Ultragenyx Pharmaceutical
―
Bluebird Bio
―
---